BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 23469321)

  • 1. Doxazosin for the treatment of nightmares: does it really work? A case report.
    Sethi R; Vasudeva S
    Prim Care Companion CNS Disord; 2012; 14(5):. PubMed ID: 23469321
    [No Abstract]   [Full Text] [Related]  

  • 2. Doxazosin, an α-1-adrenergic-receptor Antagonist, for Nightmares in Patients with Posttraumatic Stress Disorder and/or Borderline Personality Disorder: a Chart Review.
    Roepke S; Danker-Hopfe H; Repantis D; Behnia B; Bernard F; Hansen ML; Otte C
    Pharmacopsychiatry; 2017 Jan; 50(1):26-31. PubMed ID: 27276365
    [No Abstract]   [Full Text] [Related]  

  • 3. Doxazosin for the treatment of nightmare disorder: A diary-based case study.
    Pallesen S; Hamre HS; Lang N; Bjorvatn B
    SAGE Open Med Case Rep; 2020; 8():2050313X20936079. PubMed ID: 32647580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treating nightmares in PTSD with doxazosin: a report of three cases.
    Calegaro VC; Mosele PHC; Duarte E Souza I; da Silva EM; Trindade JP
    Braz J Psychiatry; 2019; 41(2):189-190. PubMed ID: 30942322
    [No Abstract]   [Full Text] [Related]  

  • 5. Evidence for Using Doxazosin in the Treatment of Posttraumatic Stress Disorder.
    Smith C; Koola MM
    Psychiatr Ann; 2016; 46(9):553-555. PubMed ID: 27667865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doxazosin XL reduces symptoms of posttraumatic stress disorder in veterans with PTSD: a pilot clinical trial.
    Rodgman C; Verrico CD; Holst M; Thompson-Lake D; Haile CN; De La Garza R; Raskind MA; Newton TF
    J Clin Psychiatry; 2016 May; 77(5):e561-5. PubMed ID: 27249080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trauma-related nightmares among American Indian veterans: views from the dream catcher.
    Shore JH; Orton H; Manson SM
    Am Indian Alsk Native Ment Health Res; 2009; 16(1):25-38. PubMed ID: 19340764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined oral therapy with sildenafil and doxazosin for the treatment of non-organic erectile dysfunction refractory to sildenafil monotherapy.
    De Rose AF; Giglio M; Traverso P; Lantieri P; Carmignani G
    Int J Impot Res; 2002 Feb; 14(1):50-3. PubMed ID: 11896478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of doxazosin on the activity of the endothelium-derived relaxing factor.
    Yeates RA
    Arzneimittelforschung; 1994 Oct; 44(10):1117-21. PubMed ID: 7818583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doxazosin modifies Bcl-2 and Bax protein expression in the left ventricle of spontaneously hypertensive rats.
    Rodríguez-Feo JA; Fortes J; Aceituno E; Farré J; Ayala R; Castilla C; Rico L; González-Fernández F; García-Durán M; Casado S; López-Farré A
    J Hypertens; 2000 Mar; 18(3):307-15. PubMed ID: 10726718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet alpha2-adrenoceptor alterations in patients with essential hypertension are normalized after treatment with doxazosin but not propranolol.
    Portaluppi F; Manfredini R; Varani K; Gessi S; Caiazza A; Borea PA
    J Hypertens; 2000 Feb; 18(2):217-21. PubMed ID: 10694191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doxazosin: a study in a cohort of patients with hypertension in general practice--an interim report.
    Langdon CG
    Am Heart J; 1991 Jan; 121(1 Pt 2):268-73. PubMed ID: 1824649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of doxazosin in the treatment of acute urinary retention due to benign prostate hyperplasia.
    Prieto L; Romero J; López C; Ortiz M; Pacheco JJ
    Urol Int; 2008; 81(1):66-71. PubMed ID: 18645274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ejaculatory disorder caused by doxazosin administration for blood pressure control in patient with pheochomocytoma].
    Amano T; Imao T; Takemae K; Yamauchi K
    Hinyokika Kiyo; 2009 Jun; 55(6):377-80. PubMed ID: 19588875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doxazosin, a case history.
    Campbell SF; Davey MJ
    Drug Des Deliv; 1986 Aug; 1(1):83-99. PubMed ID: 2978370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of doxazosin on plasma lipids and atherogenesis: a preliminary report.
    Kowala MC; Nicolosi RJ
    J Cardiovasc Pharmacol; 1989; 13 Suppl 2():S45-9; discussion S49. PubMed ID: 2471015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doxazosin modifies serotonin-mediated rabbit urinary bladder contraction. Potential clinical relevance.
    Khan MA; Thompson CS; Dashwood MR; Mumtaz FH; Mikhailidis DP; Morgan RJ
    Urol Res; 2000 Apr; 28(2):116-21. PubMed ID: 10850634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of angiotensin II receptor blockade on the interaction between enalaprilat and doxazosin in rat tail arteries.
    Marwood JF
    Clin Exp Pharmacol Physiol; 1998; 25(7-8):517-21. PubMed ID: 9673422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive effects and pharmacokinetics of single and consecutive administration of doxazosin in patients with mild to moderate essential hypertension.
    Shionoiri H; Yasuda G; Yoshimura H; Umemura S; Miyajima E; Miyakawa T; Takagi N; Kaneko Y
    J Cardiovasc Pharmacol; 1987 Jul; 10(1):90-5. PubMed ID: 2441160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study of the interaction between the hypotensive actions of doxazosin and enalaprilat in anaesthetized rats.
    Marwood JF; Tierney G; Stokes GS
    J Hypertens; 1992 Mar; 10(3):265-70. PubMed ID: 1315824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.